HB-100 series

N/A

Report date: 2025/03/20 15:46:22

NME

Base Information

Drug NameHB-100 series

Drug Alias NameProtease inhibitor (Healion)

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionProtease inhibitors

TargetsProtease

Therapy Area/IndicationsVirus Diseases

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesHealion Bio Inc

China Registration ClassN/A

Active CompaniesHealion Bio Inc

Inactive CompaniesN/A

Active IndicationsVirus Diseases

Inactive IndicationsN/A

ATC CodeN/A